Neuroscience

Neurofilament-L Blocking Peptide

イイネ!(0) Neurofilament-L Blocking Peptide Data Sheet PDF
CSTコード 包装
希望納入価格 (円)
国内在庫 i
2012年2月9日15時20分 現在
ご登録代理店情報 i
カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更はこちら
#1005S100 μg16,000
ログインすると国内在庫状況がご確認いただけます。

Neurofilament-L抗体製品一覧

用途
免疫組織染色
貯法
-20℃
使用目的
Neurofilament-L (C28E10) Rabbit mAb (#2837) の反応をブロックし、抗体の反応特異性を確認するために使用
社内データ

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded mouse brain using Neurofilament-L (C28E10) Rabbit mAb #2837 in the presence of control peptide (left) or Neurofilament-L Blocking Peptide (right).

バックグラウンド

The cytoskeleton consists of three types of cytosolic fibers: actin microfilaments, intermediate filaments, and microtubules. Neurofilaments are the major intermediate filaments found in neurons and consist of light (NFL), medium (NFM), and heavy (NFH) subunits (1). Similar in structure to other intermediate filament proteins, neurofilaments have a globular amino-terminal head, a central α-helical rod domain, and a carboxy-terminal tail. A heterotetrameric unit (NFL-NFM and NFL-NFH) forms a protofilament, with eight protofilaments comprising the typical 10 nm intermediate filament (2). While neurofilaments are critical for radial axon growth and determine axon caliber, microtubules are involved in axon elongation. PKA phosphorylates the head domain of NFL and NFM to inhibit neurofilament assembly (3,4). Neurofilament accumulations are found in many human neurological disorders including Parkinson's disease (in Lewy bodies along with α-synuclein), Alzheimer's disease, Charcot-Marie-Tooth disease, and Amyotrophic Lateral Sclerosis (ALS) (1).

  1. Al-Chalabi, A. and Miller, C.C. (2003) Bioessays 25, 346-355.
  2. Cohlberg, J.A. et al. (1995) J. Biol. Chem. 270, 9334-9339.
  3. Hisanaga, S. et al. (1994) Mol. Biol. Cell 5, 161-172.
  4. Sihag, R.K. et al. (1999) J. Neurochem. 72, 491-499.
使用例
製品をご使用いただいて研究を発表されましたら、ぜひお知らせください
 
関連製品
2837   Neurofilament-L (C28E10) Rabbit mAb

本製品は試験研究用です。

Neurofilament-L Blocking Peptide

Product Pathways

Tools

Applications